Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups

Concurrent chemoradiotherapy (CCRT) is regarded as the standard treatment for locally advanced uterine cervical cancer (LACC), including stage Ib2-IVa disease [International Federation of Gynecology and Obstetrics (FIGO) staging]. However, approximately a third of eligible patients in previous studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Todo, Yukiharu, Watari, Hidemichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Review Article on Cervical Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865615/
https://www.ncbi.nlm.nih.gov/pubmed/27199520
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.02.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865615/
https://www.ncbi.nlm.nih.gov/pubmed/27199520
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.02.10

Ejemplares similares